Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare... see more

NDAQ:INM - Post Discussion

InMed Pharmaceuticals Inc > Adams doesn't understand why the sp is so low
View:
Post by Stevemin on Sep 27, 2021 2:20pm

Adams doesn't understand why the sp is so low

In last weeks quarterly conference call, Eric Adams stated (in regards to the decline in share price) the following:
"While its difficult to ascertain the exact reason for the decline, I can assure you we are monitoring the situation closelyand are allocating additional resources toward investor related activities to increase exposure, outreach and clarifying our value proposition to the investment community".
So, Mr. Adams, no need to allocate any additional resources to solving this puzzle, I believe I can save you the time and money. Possibly the investment community has already looked over your 5 year history with the company and come to the following conclusions:
 
1) You've made a habit of continually missing timelines on milestone dates and have offered zero reasons or explanations as to why. The investment community is tiring of your "kick the can" mentality and is beginning to take note.
2) You have diluted your investors into oblivion. Your tenure has been all about you getting incentivized to raise capitalwhile making zero scientific progress (everyone loved your 33:1 reverse split - thanks for that.....)
3) Investors only have your "word of mouth" that programs are advancing/viable. You have provided zero proof.
4) The BOD and management team owns basically no shares in the company (very very few). If you dont have faith in your company, why should anyone else?
5) The lack of transparency is wearing thin. Maybe, instead of only taking softball questions from analysts, you should take questions from private investors during your qtrly reports so you field some more meaning and pointed questions. I've tried several times to ask questions but have been ignored. You look like you're trying to hide something..
 
So, Mr. Adams, no need to allocate any additional resources to figure out this "head scratcher" of a problem you have.
Try being a better CEO and the problem may fix itself. If not, November's vote could be an interesting one.....
 
Comment by Stevemin on Sep 29, 2021 1:36pm
Unfortunately today you are seeing what happens to mis-managed companies that are led by CEO's who consistently over promise and under deliver. I've warned - for literally two years - about exactly how bad Adams is as a CEO. What he has done to his shareholders, the wealth he has destroyed and the complete disregard for his shareholder base is astounding. Is there any wonder why no one ...more